Participants in new trial lost weight and did not suffer gastrointestinal byproducts associated with GLP-1 medicines ...
Daiichi Sankyo Co Ltd on Wednesday said that its breast cancer drugs, Enhertu and Datroway, which are being developed in ...
Get COVID-19 vaccine side-effects latest news, Article video and Photos on COVID-19 vaccine side-effects Explore latest health updates, news, information from TheHealthSite.com ...
NVCT stock surged on NXP100 PNH deal. Explore catalysts, dilution risk, and pipeline outlook for NXP100/NXP200/NXP900—read ...
GSK reported good clinical trial results with two of its lung cancer therapies – Jideytro and risvutatug rezetecan (ris-rez) ...
Find out what came out of the World Conference on Lung Cancer (WCLC) 2026, from late-stage successes and failures to earlier-stage promise.
BioNTech and partner OncoC4's anti-CTLA-4 immunotherapy gotistobart almost doubled survival in a trial involving patients with a hard-to-treat form of lung cancer, ahead of a pivotal readout due next ...
Analysts believe Cullinan Therapeutics and Taiho Oncology can overcome the safety risks as zipalertinib “sets [a] new bar” ...
In the phase 3 DESTINY-Lung04 trial, patients with HER2-mutant advanced non-small cell lung cancer treated with Enhertu went ...
Explore the latest oncology biotech news, from clinical data to fundraising and biotech deals, in our September 2026 roundup.
SOPHiA GENETICS SA is entering a scale-and-monetise phase, with its genomic intelligence platform. Check out more on SOPH ...
Kipsbiopharma (hereinafter Kipspharma) is set to officially begin domestic Phase 2 clinical trials for its next-generation targeted anticancer drug ca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results